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The p53 gene is probably the most frequently altered (mutation,
deletion) tumour suppressor gene in human cancer cells (Friend,
1994; Sherr, 1996). It also plays a key role in the regulation of
apoptosis and G1 arrest after treatment with DNA-damaging
agents such as irradiation. The critical biochemical function of
wild type (wt) p53 is its ability to bind to specific DNA sequences
and to activate the transcription of genes such as GADD45
(Growth Arrest after DNA Damage), Bax involved in the
regulation of apoptosis and p21 WAF1/CIP1 gene, whose product
inhibits several cyclin/cyclin-dependent kinases complexes, essen-
tial for cell cycle progression (Deng et al, 1995). Ionizing radia-
tions induce a delay both in G1 and G2. However, only the 
G1 delay appears to depend on p53 (Kastan et al, 1991). Hence
most of the transformed and cancer cells which exhibit a mutated
p53 fail to arrest in G1 after irradiation but still undergo a G2
arrest (Kastan et al, 1991).
The mechanisms underlying the radiation-induced G2 arrest are
not fully understood. The progression of cells through G2 and 
M phases is regulated in eukaryotes by MPF (mitosis promoting
factor) which includes two proteins, a cyclin (cyclin B) and a
cyclin-dependent kinase (cdk) p34cdc2 (cdk1). Another complex,
cyclin A2–cdk1, is activated before cyclin B–cdk1 and is also
required for the progression from G2 to mitosis. The kinase
activity of cdk1 depends on both its association with the cyclin
subunit and phosphorylation of specific residues. Levels of cdk1
remain relatively constant throughout the cell cycle, whereas
levels of cyclins A and B fluctuate with a maximum in M phase
(Sherr, 1996). Irradiation has been shown in mammalian cells to
induce a decrease in cdk1 activity, related to a decrease of cyclin
B1 and/or to an inhibition of cdk1 phosphorylation (Jin et al,
1996). Indeed cyclin B1 is a rate-limiting component of the
radiation-induced G2 delay (Kao et al, 1997). Down-regulation of
cyclin B1 occurs at least in part by a post-transcriptional regula-
tion of mRNA levels (Maity et al, 1995). In addition, Azzam et al
(1997) showed in various cell lines that cdk1 is down-regulated by
g-radiation through a p53-dependent mechanism.
Several studies have recently suggested that wtp53 might also
regulate the cell cycle arrest in G2/M after DNA damage (Agarwal
et al, 1995; Allday et al, 1995; Aloni-Grinstein et al, 1995;
Guillouf et al, 1995; Han et al, 1995; Powell et al, 1995; Stewart et
al, 1995; Pellegata et al, 1996; Skladanowski et al, 1997).
However, the contribution of p53 seems to be complex and to
depend on the cell type. Most studies were performed in rodent
cells and relatively little is known about this effect in human
tumour cell lines, although a recent study by Hermeking et al
(1997) has shown a p53-regulated inhibition of G2M progression
in a human rectal carcinoma model. In addition, none of these
studies has investigated the effect of p53 expression on the levels
of cyclins A2 and B1 during the G2 arrest.
In our study we further examined the consequences of irradia-
tion combined to the expression of wtp53 after gene transfer on (i)
the radio-induced G2 arrest, (ii) expression of the mitotic cyclins
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Summary In vivo transfer of wild-type (wt) p53 gene via a recombinant adenovirus has been proposed to induce apoptosis and increase
radiosensitivity in several human carcinoma models. In the context of combining p53 gene transfer and irradiation, we investigated the
consequences of adenoviral-mediated wtp53 gene transfer on the cell cycle and radiosensitivity of a human head and neck squamous cell
carcinoma line (SCC97) with a p53 mutated phenotype. We showed that ectopic expression of wtp53 in SCC97 cells resulted in a prolonged
G1 arrest, associated with an increased expression of the cyclin-dependent kinase inhibitor WAF1/p21 target gene. A transient arrest in G2
but not in G1 was observed after irradiation. This G2 arrest was permanent when exponentially growing cells were transduced by Ad5CMV-
p53 (RPR/INGN201) immediately after irradiation with 5 or 10 Gy. Moreover, levels of cyclins A2 and B1, which are known to regulate the
G2/M transition, dramatically decreased as cells arrived in G2, whereas maximal levels of expression were observed in the absence of wtp53.
In conclusion, adenoviral mediated transfer of wtp53 in irradiated SCC97 cells, which are mutated for p53, appeared to increase WAF1/p21
expression and decrease levels of the mitotic cyclins A2 and B1. These observations suggest that the G2 arrest resulted from a p53-
dependent premature inactivation of the mitosis promoting factor. © 2000 Cancer Research Campaign
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A2 and B1, and (iii) apoptosis. Since this study was designed in
the context of combining p53 gene therapy and irradiation, we
have used a recombinant adenovirus to transfer the wtp53 gene in
a head and neck squamous cell carcinoma line SCC97, which
exhibited a mutated p53 phenotype. An adenoviral vector was
used since it ensures a particularly high gene transfer efficiency,
and is commonly used in most gene therapy studies (Gallardo et al,
1996; Clayman et al, 1996).
MATERIALS AND METHODS
Cell line
The study has been performed using the human squamous cell
carcinoma cell line SCC97 (gift of G Clayman, MD Anderson,
Houston, TX, USA). Cells were grown in modified essential
medium (MEM) supplemented with 15% fetal calf serum (FCS)
with penicillin–streptomycin and 2 mM glutamine at 5% carbon
dioxide. The clonogenic survival curve after g-irradiation has been
established and the surviving fraction at 2 Gy was 59%.
SCC97 cells exhibit a mutation of p53 gene, that was character-
ized by sequencing. A point mutation (transversion T–A) at the
second base of the fifth intron inactivates the normal splicing
donor site. An alternative splicing therefore occurs between a GT
sequence in exon 5 as a donor site and the usual acceptor site. This
results in a 46 bp deletion in the coding sequence in exon 5 and a
frame-shift, leading to a truncated unstable p53 which cannot be
detected by immunofluorescence or Western blot. Western blot
analysis and flow cytometry have been performed using DO7 and
DO1 monoclonal antibodies against the N-terminal part of the
human p53 protein, showing that the mutated p53 protein was not
detectable.
Recombinant adenovirus
A human non-replicative recombinant adenovirus type 5, with a
complete deletion of E1A and a partial deletion of E3 regions was
used as vector to infect the cell line in vitro. This vector encoded
the human wtp53 gene driven by the human cytomegalovirus
(CMV) promotor. A batch was provided by RPR-Gencell (Vitry,
France, Ad5CMV-p53 RPR/INGN201). The construction and
properties of Ad5CMV-p53 have been reported elsewhere (Zhang
et al, 1994). The vector AV1.0CMV/293 was used as a control.
Viruses were propagated, purified, titrated in 293 cells transcom-
plementing for E1 gene products, and assessed for the absence 
of contaminating wild-type recombinant virus using protocols
previously described (Zhang et al, 1995). Viral titre was determined
by UV-spectrophotometric analysis (viral particle ml–1) and 
by plaque forming assay (pfu ml–1). Titres of the viral stocks 
used were between 109 and 1011 pfu ml–1. Viruses were stored 
at –80°C.
Gene delivery and fluorescence-activated cell sorter
analysis
Viruses were diluted in Dulbecco’s MEM (DMEM) supplemented
with 2% FCS in polypropylene tubes. In vitro transduction were
performed by plating 13106 cells in 75-cm2 flasks. Twenty-four
hours after plating, cells were incubated for 1 h at 37°C with
purified virus in 6 ml of MEM supplemented with 10% FCS. At
various times after infection, cells were trypsinized and fixed by
the addition of a formaldehyde solution (4% in phosphate-buffered
saline (PBS)) for 20 min at room temperature. Cells were pelleted
and permeabilized in 0.2% Triton X-100 in PBS for 10 min 
at room temperature. After three rinses in Power Block 1X
(Biogenex), cells were incubated with the anti-p53 antibody 
(p53-FITC DO7, 1/200) (Dako) for 2 h at room temperature. 
Cells were rinsed twice in Power Block and then stored at 4°C
until analysed. A control was done by incubating cells with a
mouse IgG1 fluorescein isothiocyanate (FITC) (1/100) (Becton
Dickinson) to estimate the amount of non-specific binding of
mouse monoclonal antibodies.
p53 mRNA expression
Total RNAs were extracted from SCC97 cells and mRNAs were
purified with the QuickPrep Micro mRNA Purification Kit
(Pharmacia Biotech). To determine the p53 phenotype of the cells,
a functional test was performed in yeast, which reveals the loss of
the transactivating function of the mutated p53 protein (Flaman 
et al, 1995). Briefly, p53 mRNAs were reverse transcribed 
and amplified by polymerase chain reaction (PCR). The
Saccharomyces cerevisiae strain yIG397 was co-transformed with
the reverse transcription PCR (RT-PCR) product and a linearized
expression vector (pSS16) carrying the 5¢ and 3¢ ends of the p53
open reading frame and the LEU2 gene. Yeast colonies in which a
homologous recombination between the linearized pSS16 and the
PCR product had occurred expressed constitutively p53 and were
selected on medium lacking leucine. The strain used also contains
an integrated plasmid with the ADE2 open reading frame under
the control of a p53-responsive promoter. Yeasts transformed with
a plasmid encoding wtp53 grew normally and formed white
colonies (ADE2+). Yeasts expressing mutant p53 failed to express
ADE2 and formed small red colonies because adenine is limiting
for cell growth (phenotype ADE2–).
Western blot analysis
For Western blot analysis, total cellular proteins were isolated 
by lysing the cells in 50 mM Tris–HCl pH 7.5, 50 mM sodium
chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium
dodecyl sulphate (SDS) and a protease inhibitor cocktail
(Boehringer Mannheim). Protein concentrations were determined
by the micro bacteriochlorine a (BCA) protein protein assay
reagent kit (Pierce). Proteins (50 mg) were separated on 9% (to
detect p53, cyclins A2 and B1) or 12% (to detect p21/WAF1)
SDS-polyacrylamide gels and electroblotted to Hybond-C
membranes (Amersham*). After the transfer was completed, the
membranes were stained with Ponceau S (Sigma*) to verify equal
sample loading. Membranes were probed with antibodies directed
against cyclin A2 (monoclonal 11B2G3, Dr Joëlle Sobczak-
Thépot), cyclin B1 (H433, SantaCruz Biotechnology), p53 (DO7,
Dako) and p21/WAF1 (Ab1, Oncogene Research Biotechnology
Products). These primary antibodies were diluted at 1/20 000, 
1/10 000, 1/1000 and 1/500 respectively. The bound antibodies
were detected by enhanced chemiluminescence (ECL) using an
ECL kit (Amersham*). Relative levels of cyclin A2 and B1 were
determined by scanning the blots.Analysis of apoptosis and cell cycle
Detection of apoptotic cells by flow cytometry was performed
using the in situ cell death detection kit, fluorescein by TUNEL
(terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick end labelling, Boehringer Mannheim). The TUNEL assay
was performed using a procedure previously described. Briefly,
cells were trypsinized and centrifuged with the culture medium to
pellet in the same tube attached cells and cells in suspension. Cells
were washed in bovine serum albumin (BSA) solution (1% in
PBS) and fixed in 4% paraformaldehyde (in PBS, pH 7.4) for 30
min at room temperature. Cells were pelleted and permeabilized
with 0.3% Triton X-100 in sodium citrate 0.1% for 2 min on ice.
Cells were then rinsed twice in PBS and incubated with the
TUNEL reaction mixture. A negative control was done by incu-
bating cells in the reaction mixture without terminal transferase
and a positive control was provided by incubating cells with
DNAase 1 (Boehringer Mannheim, 50 mg ml–1 in PBS, for 10 min
at room temperature) prior to the TUNEL reaction. Cells were then
washed twice in PBS and incubated for 30 min at 37°C with 10 mg
ml–1 RNAase and with propidium iodide at 500 mg ml–1. Two-
colour fluorescence analysis was done on a fluorescence-activated
cell sorter (FACS).
Cells analysed for their DNA content were fixed in ice-cold
70% ethanol and stored at –20°C until analysis. For FACS
analysis, cells were resuspended in PBS and stained with
propidium iodide as described above.
Cell synchronization
Cells were incubated with 200 mM mimosine (Sigma) which is a
plant amino-acid for 24 h to synchronize them in G1/S.
Irradiation
Cells were irradiated with a 137Cs g-ray source at a dose rate of
1.45 Gy min–1 at room temperature, in culture dishes.
RESULTS
Expression of wtp53 after adenovirus-mediated gene
transfer
Expression of wtp53 mRNA in SCC97 cells infected with
Ad5CMV-p53 was estimated using the yeast functional test
(Flaman et al, 1995). The percentage of white yeast colonies
reflected the ratio between the ectopic mRNA encoding wtp53 and
the endogeneous mRNA encoding mutant p53. We found 90% of
white colonies starting with mRNAs purified from SCC97 cells 
48 h after infection with Ad5CMV-p53. This value was indepen-
dent on the multiplicity of infection (MOI) in the range of 25–800
MOI. Using the same assay, we found that expression of wtp53
was already detectable 2 h after infection and reached a plateau 4 h
after infection (Figure 1A). These results indicated that wtp53
mRNA was efficiently expressed from the viral vector.
The proportion of cells expressing the protein wtp53 was then
determined by FACS analysis as a function of the MOI (Figure 1B,
left). A maximum of 90% of wtp53-positive cells was observed at
100 MOI. Therefore, we subsequently used this MOI to assess the
effect of wtp53 in the whole cell population, expressing wtp53
relatively homogeneously. The wtp53 protein was rapidly
expressed after infection since it was detectable by flow cytometry
4 h after infection and was maximal in 90% of cells after 10 h
(Figure 1B, right). In addition, Western blot analysis revealed that
a band corresponding to wtp53 was detected at 4 h and that the
amount of wtp53 still increased after 10 h (Figure 1C).
Combined effects of wtp53 gene transfer and
irradiation on the cell cycle
Cell cycle alterations have been studied up to 48 h after infection
with Ad5CMV-p53 and/or irradiation (Figure 2A). Adenovirus-
mediated gene transfer of wtp53 induced a cell cycle arrest in the
G1 phase in 70% of cells 24 h after infection (data not shown).
This arrest persisted at 48 h (Figure 2A) and 72 h after infection
with a percentage of cells in S phase below 10%. This arrest was
p53-dependent since cells infected with the control vector
644 C Badie et al
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Figure 1 (A) Expression of exogenous wild-type p53 mRNA in SCC97 cells
after infection with Ad5CMV-p53 at 25 MOI. The results are expressed as the
proportion (%) of white/total yeast colonies. (B) Expression of wtp53
mediated by Ad5CMV-p53 in SCC97: transduction efficiency analysis
obtained by immunofluorescence cytometry in SCC97 cells at different MOI
(B – left) and different times after infection with 100 MOI of Ad5CMV-p53
(B – right). The percentages of p53-positive cells were obtained by flow
cytometry. (C) Time course of p53 protein expression after Ad5CMV-p53
(100 MOI) infection. The blots are shown with the time in hours after infection
indicated above the lanes. After cell lysis, the proteins, separated by SDS-
PAGE, were transferred to a membrane and probed with antibodies
recognizing p53 (DO7). The band observed corresponded to wtp53 since the
endogenous p53 truncated protein in SCC97 was not recognized by the
antibody we employedAV1.0CMV/293 were not arrested and maintained an exponential
growth.
Irradiation (5 or 10 Gy) of SCC97 cells induced predominantly
a cell arrest in G2 but not in G1. This G2 arrest was reversible and
had almost completely disappeared 48 h after irradiation (Figure
2A). In contrast, when cells were infected with Ad5CMV-p53
immediately after irradiation at 2.5, 5 (data not shown) or 10 Gy,
the G2 arrest was still observed 48 h after irradiation (Figure 2A).
In addition, the fraction of cells blocked in G2 was dose-
dependent: 21% for 2.5 Gy, 41% for 5 Gy and 81% for 10 Gy. This
protracted G2 arrest was p53-dependent since cells transduced
with the control vector AV1.0CMV/293 showed a transient G2
arrest as uninfected irradiated cells (Figure 2A).
Apoptosis
The occurrence of apoptosis after p53 gene transfer and/or irradia-
tion was studied by the TUNEL assay followed by flow cytometry
24 h (data not shown) and 48 h after treatment (Figure 2B). The cell
cycle was analysed in parallel. Almost no apoptosis was detected in
control uninfected cells (0.5%) and in cells infected with the control
vector AV1.0CMV/293. When these cells were irradiated (10 Gy),
or infected by the control adenovirus, apoptosis occurred in both
cases in 26–35% of cells (Figure 2B). Infection with Ad5CMV-p53
induced apoptosis in 18% of cells, equally distributed in G1 and G2
phases of the cell cycle. This value increased to 84% when infec-
tion with Ad5CMV-p53 was performed after irradiation. These
apoptotic cells were in the G2 phase for most of them. This was a
large scale effect since no cells remained attached to the culture
dishes 72 h after irradiation and infection. In conclusion, these
results showed that the G2 arrest induced by irradiation which was
prolonged when combined to wtp53 gene transfer, was rapidly
followed by a massive apoptosis. In contrast, when cells were
infected first by Ad5CMV-p53 and subsequently irradiated, a cell
cycle arrest in the G1 phase was observed, with no significant
increase of apoptosis (data not shown).
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Figure 2 (A) Cell cycle analysis, 48 hours after treatment for control, cells infected by the control vector AV1.0CMV/293 alone (null) or associated with
irradiation (10 Gy), cells infected by Ad5CMV-p53 alone or associated with irradiation and irradiation alone. Propidium iodide stained cells were analysed by
FACS. The percentage of cells in each phase of the cell cycle (subG1, G1, S and G2/M) is shown in each panel. (B) Labelling of DNA breaks in apoptotic cells
with FITC dUTP by TUNEL method. After infection, flow cytometric analysis for apoptosis was performed at 48 h. The percentage of cells in apoptosis is shown
in the upper part of each panel. Two-colour fluorescence analysis was done on FACS: a linear gate was drawn to include all cells within a cell cycle propidium
iodide fluorescence profile and then projected onto a scatter plot of logarithmic FITC signal versus propidium iodide integral signal of fluorescenceExpression of p21, cyclin A2 and cyclin B1 in
synchronized cells after wtp53 gene transfer
To study the mechanisms underlying the cell cycle arrest after irra-
diation associated with Ad5CMV-p53 infection, we used a homo-
geneous cell population synchronized in G1/S. Figure 3 shows that
SCC97 cells were efficiently synchronized in G1/S upon treatment
with 200 mM mimosine, with 89% of cells arrested at the G1/S
boundary (T0 which represents the time of mimosine removal).
Fourteen hours after release from the mimosine block, almost all
the cells were in late S phase and in G2. Finally, 20 h after drug
release, most of the cells were in G2 and a small percentage (11%)
of them were already in G1 phase of the next cell cycle.
Irradiation of cells at the time of mimosine release (T0) did not
inhibit S phase entry but induced a delay in G2, that was clearly
observed at t = 16 h. At t = 20 h, only a few proportion of cells had
escaped the delay in G2 and were in G1, compared to the control
non irradiated cells (data not shown).
Western blot analysis showed that in control non irradiated cells
the expression of cyclins A2 and B1 peaked 14 h and 16 h after
release from the mimosine block respectively, corresponding to
cells in late S and G2 phases (data not shown). After irradiation 
(5 Gy), the maximal expression of both cyclins was delayed and
occurred between 12 and 22 h (cyclin A2) and peaked at 20 h
(cyclin B1) (Figure 4). Maximal expression of these mitotic
cyclins was therefore coincident with the delay in G2.
The expression patterns of cyclin A2 (Figure 4A) and cyclin B1
(Figure 4B) after irradiation (5 Gy) were then compared with or
without wtp53 expression. The level of expression of cyclins A2
and B1 were dramatically reduced in cells infected with wtp53, as
compared to non-infected cells (Figure 4A and B) or cells infected
with the control vector (data not shown), and decreased to unde-
tectable levels at 20–22 h. To determine if this effect was a direct
consequence of wtp53 expression, the same experiment was
repeated without irradiation. Figure 5 shows that the expression of
wtp53 alone was sufficient to decrease the expression of both
cyclins A2 and B1, without irradiation.
Finally, Figure 6 shows that p21/waf1 protein detected by
Western blot was present only after expression of wtp53 protein
and that irradiation alone did not induce p21 expression. There
was no difference regarding p21 expression between wtp53
expressing cells with or without irradiation.
DISCUSSION
In these experiments, we showed that wtp53 expression in SCC97
cells was associated with the restoration of p21 expression and a
G1 arrest. However, when wtp53 was transferred immediately
after irradiation, a prolonged G2 arrest was observed, with more
than 80% of the cells arrested in G2, 48 h after treatment, followed
by a massive apoptosis. This phenomenon was not related to the
viral infection since neither G2/M arrest nor increased apoptosis
were observed with the control null virus. In addition it was not
due to g-irradiation alone since the proportion of apoptotic cells
following irradiation alone (about 30%) was much lower than
when wtp53 was transferred after with irradiation (> 80%). Such a
large increase of apoptotic cells after irradiation has also been
observed in this histological type, using a protein kinase C
inhibitor in combination with irradiation (Chmura et al, 1997). In
addition, our results suggest that the timing of g-irradiation before
wtp53 gene transfer can be critical to obtain maximal effects in
terms of apoptosis and cell killing. These observations could have
important implications for future clinical protocols.
The wtp53-dependent G2 arrest observed in irradiated asyn-
chronous cells was also observed in cells synchronized with
mimosine, in the absence of irradiation. Indeed, when cells were
released from the mimosine block, wtp53 induced a prolonged
block in G2. This was also observed by Agarwal et al (1995) who
showed in Li–Fraumeni syndrome fibroblasts expressing wtp53
under the control of the tetracycline promotor that expression of
646 C Badie et al
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Cwtp53 without any irradiation could mediate a predominant G2
arrest when cells were released from a mimosine block. In their
case, wtp53 expression blocked the cells (for as long as 20 days)
reversibly, in contrast with our results showing a G2 arrest
followed by massive apoptosis. It should also be pointed out that
the level of expression of the exogenous wtp53 following infection
was probably much higher than the physiological one, since we
used a strong CMV promotor. However, Agarwal et al (1995)
showed that the G2/M arrest could be achieved in their model 
at physiological levels of p53. Our data suggest that the
consequences of the p53-dependent G2 arrest can vary according
to the model: massive apoptosis in our case, prolonged but
reversible G2 arrest in Agarwal model and a third consequence has
also been reported by Aloni-Grinstein et al (1995) who showed
that expression of wtp53 was able to mediate differentiation
during the G2/M growth arrest in a murine pre-B-cell line.
The influence of p53 on the G2 arrest has also been observed by
Powell et al (1995) who described a differential sensitivity of
p53(–) and p53(+) cells to caffeine induced radiosensitization.
They showed that there was a complete override of G2/M arrest in
p53(–) cells, but no impact in p53(+) cells also suggesting that
wtp53 may help cells to overcome the G2 arrest. In addition,
Winters et al (1998) reported a p53-dependent pathway which
could operate after exposure of human cells to ionizing radiation
to promote G2 arrest accompanied by nuclear translocation rather
than inhibitory phosphorylation of CDC2. Our results are in agree-
ment with these different studies. Nevertheless we observed that
wtp53 blocked the cells in G2/M and induced massive apoptosis of
these cells, which was in contrast with the studies of Skladanowski
et al (1997) and Guillouf et al (1995) who showed that wtp53 was
not able to block the cells in G2/M but could promote the exit from
the G2/M arrest induced respectively by g-irradiation and etopo-
side and then was followed by apoptosis. However, these results
were obtained with a murine myeloid leukaemia cell line which
could have a different and specific behaviour since Han et al
(1995) described an apoptosis p53-independent mechanism at the
G2 checkpoint in cells after X-irradiation in HL-60 cells (human
promyelocytic leukaemia).
The molecular mechanisms involved in the p53-regulated G2/M
arrest are under investigation. A recent study by Hermeking et al
(1997) has found that a protein called 14-3-3 sigma was a 
p53-regulated inhibitor of G2/M progression in a human cancer
cell line. In our study, we analysed the molecular mechanisms 
of this G2/M arrest by studying cyclins A2 and B1, which are
known to be implicated in the G2/M transition. Cells which
arrived in G2 expressed cyclins A2 and B1 (after irradiation alone)
with a maximal level delayed compared to the control. This was in
agreement with Muschel et al (1993) who have shown that the
expression of cyclin B1 was delayed in expression after irradia-
tion. However, in their study, cyclin A and cyclin B expression
responded differently to radiation since cyclin A2 had a peak of
expression at the same time as the control.
Various hypotheses can be generated to explain the complete
disappearance of cyclins A2 and B1 in our study. A first hypoth-
esis is that the 14-3-3 sigma protein may interfere with the expres-
sion of cyclins A2 and B1, since this protein has been recently
described as a determinant of p53-regulated G2/M arrest in a
human cancer cell line (Hermeking et al, 1997). A second hypoth-
esis is that the cyclins could be degraded by caspases, as suggested
by Stack and Newport (1997) who described degradation of 
A-type cyclins by the ICE-like caspases in Xenopus embryo
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Cyclin A2
12 h 0 h 16 h 20 h 22 h 12 h 16 h 20 h 22 h 22 h 12 h 16 h 20 h
A
Ad(5)CMVp53 5 Gy+Ad(5)CMVp53 5 Gy
Cyclin B1
12 h 0 h 16 h 20 h 22 h 12 h 16 h 20 h 22 h 22 h 12 h 16 h 20 h
B
Ad(5)CMVp53 5 Gy+Ad(5)CMVp53 5 Gy
Figure 5 Western blot analysis showing that the expression of wtp53 alone was sufficient to decrease the expression of both cyclins A2 and B1, without
irradiation. Expression of cyclins A2 and B1 by Western blotting at different times after SCC97 cells were released from the mimosine block. The hours
represent the time after release from the mimosine block at t = 0. Cells were irradiated with 5 Gy at t = 0
p21
12 h 0 h 16 h 16 h 12 h 16 h 12 h
Adp53 5 Gy+Adp53 5 Gy
Figure 6 p21 expression after irradiation alone and combined with
Ad5CMV-p53. Cells were lysed and the proteins analysed by Western
immunoblotting. Proteins, separated by SDS-PAGE, were transferred to a
membrane and probed with antibodies recognizing p21 (Ab1)G2 arrest, decrease in cyclin A2 and B1 after p53 gene transfer 649
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apoptotic cells. Indeed, in our experiment, the cyclin disappear-
ance and G2 arrest were coincident with a massive apoptosis,
favouring this hypothesis. A third possible explanation is related to
the cell-cycle-regulated ubiquitin-protein ligase complex, known
as cyclosome or anaphase-promoting complex (APC/C). It initi-
ates exit from mitosis by degrading mitotic cyclins. The human
fizzy gene (p55cdc) is the homologue of a Drosophila gene neces-
sary for cyclin A and cyclin B degradation (Townsley and
Ruderman, 1998). Up to now, very little is known about the
APC/C pathway, the role played by the Fizzy/cdc20p protein
family and how the machinery is inactivated in response to DNA
damage. However, we could hypothesize that p53 plays a role on
Fizzy transcriptional activation to prevent cells to exit from
mitosis into interphase of the next cell cycle. Finally, wtp53 may
repress transcription of both cyclins A2 and B1. In support for this
hypothesis, Yamamoto et al (1994) showed that wtp53 was able to
inhibit transcription from the cyclin A2 promoter.
P53 may also interfere with E2F activated transcription of the
cyclin A2/B1. Indeed, recent observations have clearly shown that
the transcriptional factor E2F played a determinant role in cell-
cycle regulation and was able to interact with both p53 and MDM2
(Muller, 1995). In addition, Dimri et al (1996) have demonstrated
that p21 suppressed the activity of E2F-responsive promoters as
cdk1 and that E2F was a critical target and ultimate effector of p21
action in a retinoblastoma protein (pRB)-independent pathway.
Moreover, it has been recently shown that p21, acting as a p53-
dependent cdk inhibitor played a role at the G2/M transition by
association with cyclin A–cdk and cyclin B–cdk and promoted a
transient arrest in late G2 that could contribute to late cell cycle
checkpoint controls (Dulic et al, 1998). A role of p21 in G2/M
transition has also been reported by Niculescu et al (1998).
Altogether, these data indicate that the decrease in cyclins A2 and
B1 in cells transduced by wtp53 may result from either transcrip-
tional inhibition or protein degradation. Immunoprecipitation of
cyclins A2 and B1 after pulse-chase labelling revealed an initial
inhibition of cyclins A2 and B1 expression followed by increased
degradation (our unpublished data). These preliminary results
therefore suggest that both transcriptional repression and protein
degradation could play a role in cyclins A2 and B1 disappearance
during the p53-mediated G2 arrest.
In conclusion, a protracted G2 arrest was observed when
exponentially growing SCC97 cells were infected by Ad5CMV-
p53 immediately after g-irradiation. This prolonged arrest was
followed by massive apoptotic cell death. The possibility to obtain
massive apoptosis, when delivering wtp53 gene immediately 
after irradiation, suggest that this therapeutic sequence could be 
relevant for future clinical protocols combining radiotherapy and
wtp53 gene transfer.
The G2 arrest was also observed in the absence of irradiation in
synchronized cells expressing wtp53, with a dramatic decrease in
cyclins A2 and B1.
This study is the first to show a p53-dependent down-regulation
of cyclins A2 and B1, thus providing a molecular basis for the
wtp53-dependent G2 arrest. However, the molecular mechanisms
involved in p53-mediated down-regulation of these mitotic cyclins
need further investigations and may also vary from one cellular
model to another.
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